Fouché Guillaume, Rosati Dominique, Venet Catherine, Josserand Hervé, Latorse Marie-Pascale, Debieu Danièle, Fillinger Sabine
UR BIOGER, INRAE, Université Paris-Saclay, 78850 Thiverval-Grignon, France.
La Dargoire Research Center, Bayer SAS, 69009 Lyon, France.
Microorganisms. 2022 Jul 25;10(8):1494. doi: 10.3390/microorganisms10081494.
Increased drug efflux compromises the efficacy of a large panel of treatments in the clinic against cancer or bacterial, fungal, and viral diseases, and in agriculture due to the emergence of multidrug-resistant pathogenic fungi. Until recently, to demonstrate increased drug efflux, the use of labeled drugs or fluorescent dyes was necessary. With the increasing sensitivity of detection devices, direct assessment of drug efflux has become realistic. Here, we describe a medium-throughput method to assess the intracellular drug concentration in the plant pathogenic fungus cultivated in the presence of a sublethal fungicide concentration. As a model fungicide, we used the succinate-dehydrogenase inhibitor boscalid. The boscalid concentration was assessed in the different culture fractions using mass spectrometry linked to liquid chromatography (LC-MS/MS). The ratio between the intracellular and total boscalid amount was used as an inversed proxy for the efflux activity. Using isogenic mutant strains known for their differential efflux capacities, we validated the negative correlation between the intracellular boscalid concentration and efflux activity. In addition, intra-cellular fungicide accumulation explains the susceptibility of the tested strains to boscalid. This assay may be useful in lead development when a new molecule displays good inhibitory activity against its isolated target protein but fails to control the target organism.
药物外排增加会影响临床上一大类针对癌症、细菌、真菌和病毒疾病的治疗效果,在农业领域也会因多重耐药性致病真菌的出现而产生影响。直到最近,要证明药物外排增加,还需要使用标记药物或荧光染料。随着检测设备灵敏度的提高,直接评估药物外排已成为现实。在此,我们描述了一种中通量方法,用于评估在亚致死浓度杀菌剂存在下培养的植物致病真菌中的细胞内药物浓度。作为模型杀菌剂,我们使用了琥珀酸脱氢酶抑制剂啶酰菌胺。使用与液相色谱联用的质谱法(LC-MS/MS)评估不同培养组分中的啶酰菌胺浓度。细胞内和总啶酰菌胺量之间的比率用作外排活性的反向指标。使用已知具有不同外排能力的同基因突变菌株,我们验证了细胞内啶酰菌胺浓度与外排活性之间的负相关。此外,细胞内杀菌剂积累解释了受试菌株对啶酰菌胺的敏感性。当新分子对其分离的靶蛋白显示出良好的抑制活性但无法控制靶标生物时,该测定法可能有助于先导化合物的开发。